Printer Friendly

Ideal intravenous anaesthetic agent for modified ECT--thiopentone or propofol--a comparative study.

BACKGROUND

The use of electroconvulsive therapy (ECT) to provoke a generalised epileptic seizure was first described in 1938 and was performed without anaesthesia for almost 30 years. (3) A delicate balance needs to be maintained to achieve an adequate anaesthetic state along with an optimal duration of EEG seizure activity. Since then, it has continued to occupy a central place amongst treatment modalities for a large variety of psychiatric illnesses like severe acute depression with suicidal tendency, acute mania, schizophrenia, catatonic psychosis and delirium where pharmacotherapy failed. [4] The essential elements of anaesthesia for ECT include rapid loss of consciousness, effective attenuation of the haemodynamic response to the electrical stimulus, avoidance of gross movements, minimal interference with seizure activity, and prompt recovery of spontaneous ventilation, and consciousness. Use of general anaesthetic techniques with a rapid onset and recovery is essential to facilitate fast tracking. The purpose of this study was to compare the effectiveness of thiopentone and propofol as an intravenous agent for modified ECT in view of haemodynamic parameters, induction time and quality, seizure duration and recovery characteristic in a prospective, randomised, double-blind trial.

MATERIALS AND METHODS

After approval from institutional ethical committee and consent from patient and relatives; 60 patients of ASA I and II of either sex, aged 18-60 years scheduled for MECT were studied prospectively over one-year period. Patients with a history of full stomach, major illnesses like TB, bronchial asthma, drug allergy, neuromuscular disorders, acute respiratory disorder, hypertension, epilepsy, cardiovascular disease were excluded from our study. All the patients were randomly allocated by computerised randomisation table into two groups of 30 each according to intravenous anaesthetic drugs administered for induction of anaesthesia in this double-blind trial. Group I and Group II received Thiopentone (2.5%) -5 mg/kg, Propofol (1%) -2 mg/kg, respectively.

All the patients were kept nil orally for six hours before procedure and allowed to continue respective antipsychotic treatment till the day of procedure.

Intravenous line was secured. Multipara (Philips MP30) was attached for monitoring heart rate, NIBP, RR, SpO2 and the psychiatrist was allowed to place bitemporal ECT electrodes on forehead.

All the patients were premedicated with IV glycopyrrolate 0.2 mg and preoxygenated for three minutes. General anaesthesia was induced with intravenous anaesthetic agent as per the group allocated till loss of eyelid reflex. Then, intravenous succinylcholine 0.5 mg/kg was administered to all the patients for neuromuscular relaxation. When fasciculations subsided and adequate neuromuscular relaxation obtained, adequate size Guedel's airway was inserted to prevent tongue bite, and brief pulse stimulus (90120 volts MECT) for about 2 msec was given to produce seizure. Subsequently, all the patients were ventilated with 100% oxygen at the rate of 12 breaths per minute until spontaneous breathing returned, and patients fully recovered clinically. All the patients were monitored for changes in haemodynamics HR, SBP, DBP, arterial oxygen saturation, ECG changes and respiratory rate throughout the procedure. Besides induction time (i.e., from time of injecting intravenous anaesthetic agent to loss of eyelash reflex) and quality of induction; seizure duration, side effects, recorded in both the groups. Duration of recovery (Cognitive, orientation and neuromuscular co-ordination) was recorded from injection of intravenous anaesthetic agent to time taken to obey verbal commands, opening of eye, ability to sit unaided and meet discharge criteria [Table 1].

The collected data was entered in the master chart. The results were analysed statistically by percentage, mean, standard deviation and Z tests.

RESULTS

The demographic characteristics as shown in Table 2 were comparable in both groups. Maximum number of patients were schizophrenic males in both groups.

Mean duration of induction was shortest with Group II as compared to Group I (P<0.001, highly significant) as shown in Table 2. Induction of anaesthesia was smooth with propofol compared to thiopentone.

* A minimum score of 7/8 (and/or return to same preoperative status) is achieved prior to transferring the patient to a Phase III recovery area or home (Earlier minimum score of 9/10 was there in Post-anaesthetic discharge scoring system (PADSS) but in the present study, category of surgical bleeding has been omitted as there was no need of this category).

After application of ECT, significant rise in HR, SBP, DBP was observed up to 3 minutes in both the groups, but these were highly significant in thiopentone group [Tables 3 and 4].

The decrease in duration of seizure was highly significant in propofol compared to thiopentone (P < 0.001) [Table 2].

DISCUSSION

In recent years, ECT has assumed an increasingly important role in the treatment of severe and medication-resistant depression and mania as well as in the treatment of schizophrenic patients with affective disorders, suicidal drive, delusional symptoms, vegetative dysregulation, inanition, and catatonic symptoms. (5)

In the present study, the dose used for induction was calculated according to the body weight which was adequate to reach the induction criteria i.e. loss of eyelid reflex and could not interfere with the ECT induced seizure.

In the present study, induction was rapid with propofol as compared to thiopentone, which was statistically significant (P < 0.05). (1,2)

Induction was smooth with propofol in comparison to thiopentone. Mean seizure duration was significantly short in propofol compared to thiopentone group. Though significant shortening of seizure duration was observed with propofol which was above 25 seconds, it does not affect modified ECT efficacy or therapeutic outcome. Duration of seizure activity lasting for >25 sec. in single session or a maximum of 210 sec. of cumulative duration leads to good therapeutic outcome. [6] Elevation of seizure threshold after Propofol administration may explain the lower duration of seizure.

Increase in heart rate, SBP and DBP after ECT was observed in both groups, but it was statistically highly significant in thiopentone group. Propofol blunts the sympathetic response, so there was less increase in HR, SBP and DBP. The significant rise in HR after ECT with thiopentone as compared to propofol was also noted by Boey WK et al, [7] Arya A et al [8] and Singhal SK et al. [9] In this study, propofol seems superior to thiopentone in attenuating the physiological response to ECT with minimal haemodynamic changes. Arrhythmias occurred only in 6.67% patients in thiopentone group, which were transient and resolved spontaneously.

A significant difference in recovery time was observed among the groups. Propofol group had significantly earliest and smooth recovery (P < 0.05), followed by thiopentone with respect to time for the ability to obey verbal command, ability to sit unaided. The mean time taken to meet discharge criteria was also significantly (P < 0.05) least in propofol group (11.59 min) similar to other studies. An early recovery helps in early discharge to home. [7,8,10]

CONCLUSION

To conclude, propofol in the dosage of 2 mg/kg body weight intravenously can be safely used for modified ECT in ASA Grade I and II patients. Fast, smooth induction, early smooth recovery, better haemodynamics, make propofol as an agent of choice for day care procedure.

REFERENCES

(1.) Edelist G. A comparison of propofol and thiopentone as induction agent in outpatient surgery. CJA 1987; 34(2):110-6.

(2.) Vattonen M, Kanto J, Rosenberg P. Comparison of propofol and thiopentone for induction of anaesthesia for elective caesarean section. Anaesthesia 1989; 44(9):758-62.

(3.) Ding Z, White PF. Anesthesia for electroconvulsive therapy. Anesth Analg 2002; 94(5):1351-64.

(4.) Kalinowsky LB. History of convulsive therapy. Ann N Y Acad Sci 1986; 462:1-4.

(5.) Geretsegger C, Rochowanski E, Kartnig C, et al. Propofol and methohexital as anesthetic agents for electroconvulsive therapy (ECT): a comparison of seizurequality measures and vital signs. J ECT 1998; 14(1):28-35.

[6.] Weiner RD. The psychiatric use of electrically induced seizures. Psychiatry 1979; 136(12):1507-17.

[7.] Boey WK, Lai FO. Comparison of propofol and thiopentone as anaesthesia agents for electroconvulsive therapy. Anaesthesia 1990; 45(8):623-8.

[8.] Arya A, Singh M, Gurwara AK. A comparison of thiopentone sodium, propofol and midazolam for electroconvulsive therapy. J Anaesthesiol Clin Pharmacol 2008; 24:291-4.

[9.] Omprakash TM, Ali MI, Anand B, et al. Comparison of thiopentone sodium and propofol in ECT anaesthesia. Indian J Psycho Med 2008; 30:48-50.

[10.] Singhal SK, Dey N, Bhardwaj M, et al. Comparison of propofol and thiopentone sodium as induction agents for modified electroconvulsive therapy. J Anesth 2002; 18:393-6.

Ravindra S, Giri (1), Md. Mukkarram Iqbal (2), Md. Furquan Inamdar (3)

(1) Professor, Department of Anaesthesia, M.R. Medical College, Kalaburagi.

(2) Assistant Professor, Department of Anaesthesia, M.R. Medical College, Kalaburagi.

(3) Postgraduate, Department of Anaesthesia, M.R. Medical College, Kalaburagi.

Financial or Other, Competing Interest: None.

Submission 07-10-2016, Peer Review 31-10-2016, Acceptance 07-11-2016, Published 14-11-2016.

Corresponding Author:

Dr. Ravindra S. Giri, H. No. 2-909/67/49, Swastik Nagar, Kalaburagi-585105, Karnataka.

E-mail: mdfurquan16@gmail.com

DOI: 10.14260/jemds/2016/1527

Table 1. Post-anaesthetic Discharge Scoring System

Category              Description of Status            PADSS

Vital signs         Within 20% range of pre-op           2
                              value
                    Within 20% to 40% range of           1
                           pre-op value
                    >40% range of pre-op value           0

Respiratory   [O.sub.2] saturation >94% on room air      2
status          [O.sub.2] saturation >94% on nasal       1
                      prongs @ 4 LPM or less
               [O.sub.2] saturation >94% on FM @ 10      0
                           LPM or less

Nausea and          Minimal, treated with oral           2
vomiting                   medications
                      Moderate, treated with             1
                      parenteral Medications
                     Continues after repeated            0
                            treatments

Pain             Acceptable to patient (with oral        2
                           medications)
                   Pain somewhat acceptable to           1
                             patient
                  Pain not acceptable to patient         0

Table 2

Parameters                      Group I              Group II

Age (yrs.)                30.4 [+ or -] 10.55   27.33 [+ or -] 8.06
Sex (M/F)                        24/6                  27/3
Weight (kg)               51.8 [+ or -] 5.93     53 [+ or -] 5.92
Duration of               50.6 [+ or -] 6.82    41.03 [+ or -] 6.11
  induction(sec.)
Seizure duration (sec.)   36.26 [+ or -] 4.83   26.36 [+ or -] 2.79

Table 3. Mean Heart Rate at Various Time Interval

Time interval           Group I                Group II

Basal              82.3 [+ or -] 4.25    84.53 [+ or -] 4.27
After induction   85.07 [+ or -] 5.44           84.70
After ECT 1       120.23 [+ or -] 9.88   109.36 [+ or -] 7.83
2                 124.76 [+ or -] 8.26   107.2 [+ or -] 6.99
3                 119.3 [+ or -] 7.45     103.1 [+ or -] 7.1
5                 99.33 [+ or -] 6.77    90.23 [+ or -] 6.69
10                88.36 [+ or -] 6.21    88.99 [+ or -] 5.43
20                87.66 [+ or -] 6.66     85.4 [+ or -] 6.69
30                  87 [+ or -] 6.63     84.57 [+ or -] 6.23

Table 4

Systolic BP

                            I                      II

Basal              124.3 [+ or -] 6.83    123.9 [+ or -] 7.33
After induction   121.03 [+ or -] 8.42    120.9 [+ or -] 7.13
1                 158.23 [+ or -] 11.81   134.22 [+ or -] 9.28
2                 146.24 [+ or -] 11.61   130.66 [+ or -] 8.36
3                 138.2 [+ or -] 11.66    124.33 [+ or -] 8.11
5                 128.21 [+ or -] 8.30    122.67 [+ or -] 6.67
10                126.67 [+ or -] 8.28    122.36 [+ or -] 7.68
20                122.22 [+ or -] 7.88    121.22 [+ or -] 6.98
30                121.22 [+ or -] 7.82     121 [+ or -] 6.25

Diastolic BP

                            I                      II

Basal              76.7 [+ or -] 4.43      78.5 [+ or -] 4.63
After induction    79.23 [+ or -] 6.21     81.2 [+ or -] 5.53
1                 99.23 [+ or -] 10.26    90.66 [+ or -] 7.53
2                  93.36 [+ or -] 7.82    85.66 [+ or -] 7.76
3                  87.23 [+ or -] 7.36    81.12 [+ or -] 4.95
5                  83.2 [+ or -] 5.67      78.7 [+ or -] 4.62
10                 79.2 [+ or -]  4.36    78.23 [+ or -] 4.12
20                 77.86 [+ or -] 4.12     76.1 [+ or -] 4.26
30                 77.36 [+ or -] 3.96    75.23 [+ or -] 3.89
COPYRIGHT 2016 Akshantala Enterprises Private Limited
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2016 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Title Annotation:Original Research Article; electroconvulsive therapy
Author:Ravindra, S.; Giri; Iqbal, Md. Mukkarram; Inamdar, Furquan
Publication:Journal of Evolution of Medical and Dental Sciences
Article Type:Report
Date:Nov 14, 2016
Words:1966
Previous Article:Choristoma of liver--a case report.
Next Article:Obstructed umbilical hernia in a patient of Hurler's syndrome--a case report.
Topics:

Terms of use | Privacy policy | Copyright © 2019 Farlex, Inc. | Feedback | For webmasters